Moberg Pharma AB (publ) Net Asset Quality Index
Moberg Pharma AB (publ) net asset quality index. Moberg Pharma AB (publ) (MOB) has a Net Asset Quality Index of 97.5% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr682.26 Million minus total liabilities of Skr17.04 Million yields net assets of Skr665.22 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Moberg Pharma AB (publ) book value and equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Moberg Pharma AB (publ) (2008–2025)
Net asset quality index of Moberg Pharma AB (publ) from 2008 to 2025. This chart shows how Moberg Pharma AB (publ)'s Net Asset Quality Index has evolved across 18 annual periods from 2008 to 2025. As of December 2025, the index stands at 97.5%, representing net assets of Skr665.22 Million against total assets of Skr682.26 Million SEK. Check Moberg Pharma AB (publ) strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Moberg Pharma AB (publ) Net Asset Quality Index by Year (2008–2025)
Moberg Pharma AB (publ) net asset quality index by year from 2008 to 2025. The table below presents the year-by-year Net Asset Quality Index for Moberg Pharma AB (publ) from 2008 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Moberg Pharma AB (publ).
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 97.5% | Skr665.22 Million | Skr682.26 Million | Skr17.04 Million | ▲ +0.2 pp |
| 2024 | 97.3% | Skr686.82 Million | Skr706.09 Million | Skr19.27 Million | ▲ +1.1 pp |
| 2023 | 96.2% | Skr610.73 Million | Skr634.73 Million | Skr24.01 Million | ▲ +1.7 pp |
| 2022 | 94.5% | Skr533.58 Million | Skr564.42 Million | Skr30.84 Million | ▼ -1.7 pp |
| 2021 | 96.3% | Skr434.05 Million | Skr450.89 Million | Skr16.84 Million | ▲ +14.0 pp |
| 2020 | 82.3% | Skr395.58 Million | Skr480.58 Million | Skr85.00 Million | ▲ +1.4 pp |
| 2019 | 80.9% | Skr105.68 Million | Skr130.59 Million | Skr24.91 Million | ▲ +33.5 pp |
| 2018 | 47.5% | Skr594.02 Million | Skr1.25 Billion | Skr657.60 Million | ▲ +2.3 pp |
| 2017 | 45.2% | Skr552.41 Million | Skr1.22 Billion | Skr670.85 Million | ▼ -0.4 pp |
| 2016 | 45.6% | Skr561.62 Million | Skr1.23 Billion | Skr670.55 Million | ▼ -43.2 pp |
| 2015 | 88.8% | Skr352.82 Million | Skr397.45 Million | Skr44.63 Million | ▲ +4.3 pp |
| 2014 | 84.4% | Skr303.75 Million | Skr359.72 Million | Skr55.97 Million | ▲ +10.3 pp |
| 2013 | 74.2% | Skr201.49 Million | Skr271.61 Million | Skr70.11 Million | ▲ +10.7 pp |
| 2012 | 63.5% | Skr178.23 Million | Skr280.76 Million | Skr102.53 Million | ▼ -19.6 pp |
| 2011 | 83.1% | Skr76.79 Million | Skr92.45 Million | Skr15.67 Million | ▲ +77.5 pp |
| 2010 | 5.6% | Skr687.70K | Skr12.38 Million | Skr11.69 Million | ▼ -80.0 pp |
| 2009 | 85.6% | Skr30.21 Million | Skr35.30 Million | Skr5.09 Million | ▲ +18.2 pp |
| 2008 | 67.4% | Skr15.23 Million | Skr22.59 Million | Skr7.36 Million | — |